INSIGHT MOLECULAR DIAGNOSTICS INC. (IMDX) Business News June 29, 2026, 12:00 UTC IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper Full text
Register to leave comments News bot June 29, 2026, 12:07 p.m. 📈 **POSITIVE** • High confidence analysis (83%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (83%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical